<DOC>
	<DOCNO>NCT02319525</DOCNO>
	<brief_summary>The study compare efficacy usual education material individualize computerized decision guide decision conflict patient lupus nephritis make treatment decision regard immunosuppressive therapy .</brief_summary>
	<brief_title>Individualized Patient Decision Making Treatment Choices Among Minorities With Lupus</brief_title>
	<detailed_description>The propose study , randomize control trial [ RCT ] , evaluate method assist minority lupus patient ( African-Americans Hispanics ) make share decision management lupus nephritis consider best . We develop individualized patient decision guide culturally sensitive since develop solely base value , belief preference minority patient . We test effectiveness individualize decision aid African-American Hispanic lupus nephritis patient 2-arm randomized trial include 200 patient . We hypothesize use decision-aid associate reduction decisional conflict inform choice compare usual care group ( American College Rheumatology [ ACR ] lupus pamphlet ; co-primary effectiveness outcome ) , clinically meaningful patient-centered outcome . We choose low-literacy decisional conflict scale primary outcome , since validate measure , commonly use outcome measure decision aid RCTs . We use informed choice co-primary outcome , since conceptually immediate intervention . It measure whether knowledge risk benefit immunosuppressive drug , patient value concordant choice immunosuppressive drug . Secondary outcome include patient involvement decision-making ( concordance control preference scale ) patient-physician communication ( Interpersonal Processes Care ( IPC ) score analysis audiotaped physician-patient Interaction ( use Active Patient Participation Coding Scheme ( APPC ) ) . Since plan recruit patient current lupus nephritis flare ( make current decision immunosuppressive drug ) past lupus nephritis flare ( make decision future lupus nephritis flare ) , two secondary outcome ( control preference scale concordance preferred real role decide immunosuppressive drug audiotaped physician-patient interaction immunosuppressive drug ) analyze patient current lupus nephritis flare , subset entire cohort .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>adult female lupus nephritis patient , currently flare lupus nephritis consider change initiation immunosuppressive medication ( current flare ) flare lupus nephritis past risk future lupus nephritis flare ( future flare ) male ; lupus lupus nephritis ; change lupus immunosuppressive treatment already make current flare ; end stage renal disease dialysis ; renal transplant candidate renal transplant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>lupus nephritis</keyword>
	<keyword>lupus</keyword>
	<keyword>decision-making</keyword>
	<keyword>minority</keyword>
	<keyword>immunosuppressive medication</keyword>
	<keyword>decision-aid</keyword>
	<keyword>treatment</keyword>
	<keyword>Decision conflict</keyword>
	<keyword>SLE</keyword>
</DOC>